company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1178000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-245000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,993000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4321000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15283000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15283000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-348000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1297000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,949000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,949000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,120000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,120000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,120000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14214000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14233000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14233000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1198000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-244000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1574000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45383000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,33678000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,33678000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-529000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-486000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-486000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,352000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,352000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,352000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33544000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15003000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15003000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1280000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-245000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1166000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,350000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12452000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12452000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-655000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-7000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-662000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-662000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,441000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,441000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,441000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12673000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16150000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16150000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1281000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,734000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1524000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1321000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13932000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13932000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-497000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-461000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-461000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87980000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1806000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,89786000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,89786000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,75393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19483000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19483000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1163000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-244000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2607000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4392000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11565000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11565000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-554000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-592000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-592000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,716000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,716000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,716000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11441000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12753000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12753000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1154000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-245000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2947000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3572000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12469000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12469000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-280000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-298000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-298000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1374000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1374000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1374000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18669000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18669000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1146000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-244000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2329000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21357000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5919000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5919000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-948000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-948000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-948000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1917000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1917000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1917000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1170000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,733000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2593000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1745000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16173000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16173000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1126000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1130000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1130000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2981000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2981000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2981000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14322000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25192000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25192000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1174000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3905000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-893000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21006000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21006000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-966000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1012000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1012000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,94006000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,688000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,94694000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,94694000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,72676000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1162000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2763000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1235000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21703000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21703000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1072000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,34000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1038000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1038000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-15000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,163000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,148000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,148000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22593000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1351000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1351000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1173000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2999000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5978000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5978000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-377000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,12000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-307000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-307000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1367000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1367000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1367000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4918000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1132000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2866000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6265000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11612000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11612000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1355000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1339000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1339000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1808000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1808000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1808000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11143000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11226000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11226000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1162000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4813000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18324000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23575000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23575000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-572000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-572000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-572000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4025000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4025000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4025000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20122000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3812000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3812000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1145000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3753000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6764000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1946000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1946000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1725000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1726000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1726000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3030000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3030000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3030000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3250000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37451000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37451000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1121000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16904000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6326000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13100000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13100000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1502000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1502000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1502000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14012000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1170000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3930000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2478000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18921000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18921000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3473000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3473000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3473000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,579000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,579000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,579000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21815000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22282000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22282000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1389000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5803000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3809000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18899000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18899000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1708000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1708000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1708000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,144000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,144000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,144000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20463000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13635000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13635000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1429000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4559000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-35107000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15484000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15484000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-882000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-882000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-882000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1172000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1172000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1172000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15194000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21618000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21618000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1413000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3785000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23965000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7545000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7545000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1916000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-522000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2438000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2438000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,116000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,116000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,116000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5223000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30474000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30474000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1282000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2878000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2139000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28453000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28453000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2919000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,522000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2397000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2397000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,197132000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,197132000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,197132000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,166282000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33740000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33740000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1127000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5236000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3974000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31351000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31351000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3377000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3377000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3377000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4462000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4462000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4462000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30266000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33227000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33227000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1260000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3350000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5522000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34139000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34139000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,329000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,329000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,329000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35560000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1435000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4872000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-458000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26079000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26079000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3479000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3479000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3479000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,188000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,188000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,188000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29370000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45922000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45922000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1505000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3049000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8461000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32907000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32907000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1770000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1770000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1770000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,96608000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,182000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96790000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96790000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,62113000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44731000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44731000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1528000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4342000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8983000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-47844000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-47844000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1182000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1182000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1182000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2016-11-04 16:13:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49026000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17345000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17345000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1506000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3534000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20654000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32959000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32959000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-437000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-437000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-437000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-33396000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8867000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8867000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1428000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,442000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,31076000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,24079000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,24079000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-342000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-342000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-342000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,32000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23769000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56682000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56682000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1373000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20937000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80306000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45934000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45934000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-68000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-68000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-68000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1683000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,331000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1352000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1352000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44514000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13118000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13118000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1656000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-696000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17251000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29409000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29409000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-269000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-269000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-269000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,101663000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,287000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101934000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101934000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,72256000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4685000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38613000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38613000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2527000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-585000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13284000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49955000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49955000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1028000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1028000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1028000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2259000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2259000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2259000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48724000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41624000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41624000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2529000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1710000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2059000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35326000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35326000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1099000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1099000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1099000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,162540000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,560000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,163100000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,163100000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,126675000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46807000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46807000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1136000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1984000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-39856000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-39856000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2093000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2093000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2093000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-28000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,124000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41853000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1219000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2279000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1574000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41285000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41285000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1026000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1026000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1026000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1358000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1358000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1358000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40953000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,95000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1200000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2022000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,54776000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10203000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10203000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2127000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2127000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2127000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,68000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8144000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43446000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43446000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1238000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-45000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11240000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31013000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31013000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-228000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-228000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-228000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,670000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,670000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,670000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30571000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,839000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5231000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8858000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-407000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-407000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-407000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35334000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4814000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4814000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1331000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10203000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29250000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32557000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32557000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-83000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2312000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2229000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2229000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2062000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2062000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2062000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28266000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,95000.0
